Țaranu Ioana, Iancu Mihaela, Lazea Cecilia, Alkhzouz Camelia, Răcătăianu Nicoleta, Cătană Cristina-Sorina, Mirea Andreea-Manuela, Miclea Diana, Bolboacă Sorana D, Drugan Cristina
Department of Medical Informatics and Biostatistics, Iuliu Hațieganu University of Medicine and Pharmacy, Louis Pasteur Str., No. 6, 400349 Cluj-Napoca, Romania.
Pediatric Clinic 1, Emergency Pediatric Hospital, Calea Moților, No. 68, 400370 Cluj-Napoca, Romania.
J Clin Med. 2022 Jun 23;11(13):3634. doi: 10.3390/jcm11133634.
Childhood obesity progresses to metabolic disturbances via low-grade inflammation. Identifying novel molecules that reflect the activity of the immune responses is critical in understanding its underlying pathogenesis. Our exploratory study aimed to evaluate the change of chitotriosidase (CHIT1) plasma activity according to Body Mass Index (BMI)-for-age z score in pediatric patients. The study evaluated 68 children consisting of 47.1% girls with a mean age of 12.47 ± 3.71 years and 52.9% boys with a mean age of 11.93 ± 3.18 years. The effect of the most frequent CHIT1 gene variants, the 24 base pair duplication (dup24) and G102S polymorphism, upon the association between circulating CHIT1 activity and the obesity level, was also investigated. A significantly higher logCHIT1 plasma activity was found in children with extreme obesity than in children with overweight (p = 0.048 for the uncorrected CHIT1 and 0.026 for the corrected CHIT1). The BMI-for-age z score significantly (p = 0.031) predicts increased CHIT1 activity in children with overweight, obesity, and extreme obesity after controlling for the two gene variants, age, gender, and time since weight gain. Dup24 and G102S polymorphism were significant independent predictors (p-values < 0.002) for the change of CHIT1 plasma activity. Circulating CHIT1 might be an accurate indicator of inflammation in children with obesity. Its role and the effect of the dup24 and G102S variants on the CHIT1 activity should be validated in a larger cohort.
儿童肥胖通过低度炎症发展为代谢紊乱。识别反映免疫反应活性的新分子对于理解其潜在发病机制至关重要。我们的探索性研究旨在评估儿科患者中血浆壳三糖苷酶(CHIT1)活性随年龄别体重指数(BMI)z评分的变化。该研究评估了68名儿童,其中47.1%为女孩,平均年龄为12.47±3.71岁,52.9%为男孩,平均年龄为11.93±3.18岁。还研究了最常见的CHIT1基因变异,即24碱基对重复(dup24)和G102S多态性,对循环CHIT1活性与肥胖水平之间关联的影响。发现极度肥胖儿童的logCHIT1血浆活性显著高于超重儿童(未校正的CHIT1为p = 0.048,校正后的CHIT1为0.026)。在控制了两种基因变异、年龄、性别和体重增加后的时间后,年龄别BMI z评分显著(p = 0.031)预测超重、肥胖和极度肥胖儿童的CHIT1活性增加。Dup24和G102S多态性是CHIT1血浆活性变化的显著独立预测因子(p值<0.002)。循环CHIT1可能是肥胖儿童炎症的准确指标。其作用以及dup24和G102S变异对CHIT1活性的影响应在更大的队列中进行验证。